Discover open access scientific publications

Search, annotate, share and cite publications

Publications by A. C. Good

Engineering Human Immunodeficiency Virus 1 Protease Heterodimers as Macromolecular Inhibitors of Viral Maturation.

Proceedings of the National Academy of Sciences of the United States of America

Multidisciplinary

1996

English

Related publications

Novel Human Immunodeficiency Virus Type 1 Protease Mutations Potentially Involved in Resistance to Protease Inhibitors

Antimicrobial Agents and Chemotherapy

Infectious Diseases

Pharmacology

2005

English

Constrained Evolution of Human Immunodeficiency Virus Type 1 Protease During Sequential Therapy With Two Distinct Protease Inhibitors

English

Individual Contributions of Mutant Protease and Reverse Transcriptase to Viral Infectivity, Replication, and Protein Maturation of Antiretroviral Drug-Resistant Human Immunodeficiency Virus Type 1

English

Synthesis and Biological Evaluation of Novel Isopropanolamine Derivatives as Non-Peptide Human Immunodeficiency Virus Protease Inhibitors

Chemical and Pharmaceutical Bulletin

English

Do Protease Inhibitors Increase Preterm Births in Human Immunodeficiency Virus-Infected Patients?

Advances in Infectious Diseases

2013

English

Defining the Level of Human Immunodeficiency Virus Type 1 (HIV-1) Protease Activity Required for HIV-1 Particle Maturation and Infectivity.

English

Modular Total Chemical Synthesis of a Human Immunodeficiency Virus Type 1 Protease

English

Cross-Resistance Analysis of Human Immunodeficiency Virus Type 1 Variants Individually Selected for Resistance to Five Different Protease Inhibitors

Antimicrobial Agents and Chemotherapy

Infectious Diseases

Pharmacology

1995

English

Inhibition of Human and Simian Immunodeficiency Virus Protease Function by Targeting VPX-Protease-Mutant Fusion Protein Into Viral Particles.

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by A. C. Good

Engineering Human Immunodeficiency Virus 1 Protease Heterodimers as Macromolecular Inhibitors of Viral Maturation.

Related publications

Novel Human Immunodeficiency Virus Type 1 Protease Mutations Potentially Involved in Resistance to Protease Inhibitors

Constrained Evolution of Human Immunodeficiency Virus Type 1 Protease During Sequential Therapy With Two Distinct Protease Inhibitors

Individual Contributions of Mutant Protease and Reverse Transcriptase to Viral Infectivity, Replication, and Protein Maturation of Antiretroviral Drug-Resistant Human Immunodeficiency Virus Type 1

Synthesis and Biological Evaluation of Novel Isopropanolamine Derivatives as Non-Peptide Human Immunodeficiency Virus Protease Inhibitors

Do Protease Inhibitors Increase Preterm Births in Human Immunodeficiency Virus-Infected Patients?

Defining the Level of Human Immunodeficiency Virus Type 1 (HIV-1) Protease Activity Required for HIV-1 Particle Maturation and Infectivity.

Modular Total Chemical Synthesis of a Human Immunodeficiency Virus Type 1 Protease

Cross-Resistance Analysis of Human Immunodeficiency Virus Type 1 Variants Individually Selected for Resistance to Five Different Protease Inhibitors

Inhibition of Human and Simian Immunodeficiency Virus Protease Function by Targeting VPX-Protease-Mutant Fusion Protein Into Viral Particles.